Delivery Order SPE2DB22D9101-SPE2DB25FU7ML
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,631.60 on July 22, 2025, for Mitosol 0.2 mg kits. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is funded by the Defense Logistics Agency's Medical Supply Chain division. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the broader...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $1,315.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the provision of Mitosol 0.2mg kits, a pharmaceutical product, with a period of performance through April 4, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery vehicle (IDV) contract 4600082013 with the DLA, valued at up...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $23,684.40, is for the delivery of MITOSOL 0.2MG KITS 3S and has a period of performance through June 28, 2024. This order is issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $6,579.00, is for the delivery of the pharmaceutical product MITOSOL 0.2 MG KITS. This order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, held by DMS Pharmaceutical Group with DLA, valued at up to $4,999,999 through the end of 2025. Through this IDV, DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $7,894.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 4564839855 kits of the drug Mitosol (mitomycin) 0.2 mg. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group that has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,947.40, is for the delivery of Mitosol 0.2 mg kits, a pharmaceutical product. The contract has a firm fixed price and runs through May 15, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999,...
- This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $7,894.80 contract was awarded on June 21, 2023 by the Defense Logistics Agency (DLA) to provide 4,561,344,845 units of the medical product Mitosol 0.2 mg kits. The delivery order has an ultimate completion date of July 13, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 single-award indefinite delivery contract...
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the delivery of MITOSOL 0.2 MG KITS. The contract, which has a potential value of $7,894.80, has a completion date of March 11, 2024. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that provides a wide range of brand and generic prescription and over-the-counter drug supplies to government...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,158 contract is for the delivery of MITOSOL 0.2 MG kits to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group that covers a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract, valued at $6,579.00, is for the delivery of MITOSOL 0.2 MG KITS with a period of performance through March 29, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, contract number SPE2DB24FYN58, with a ceiling value of up to $4,999,999 that DMS Pharmaceutical...
- SPE2DB22D9101Indefinite Delivery Contract
- SPE2DB22D9101-SPE2DB25FU7MLDelivery Order
The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Mitosol 0.2 mg kits. This firm fixed-price delivery order, valued at $1,315.80, was awarded on July 24, 2025, with an ultimate completion date of August 14, 2025. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis in the federal procurement marketplace. The place of performance is located in Park Ridge, Illinois, where the contractor maintains its primary operations. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide. Mitosol, an ophthalmic antimetabolite used in eye surgery, represents one of the specialized pharmaceutical products available through this framework agreement, demonstrating DMS Pharmaceutical Group's role as a critical supplier in the federal pharmaceutical supply chain for military health services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/24/25 |